Both in Pharmaceuticals
Pfizer vs Johnson & Johnson
Over the past year PFE returned +23.8% and JNJ returned +46.7%; their daily moves had a correlation of 0.34.
PFE +23.8% JNJ +46.7%Growth of $1, one year, split-adjusted
| Metric | PFE | JNJ |
|---|---|---|
| Price | $30.52 | $273.20 |
| Market cap | $173.95B | $657.68B |
| Today | +1.90% | −0.73% |
| 1 month | +8.5% | +5.6% |
| 6 months | +15.9% | +20.3% |
| Year to date | +22.6% | +32.0% |
| 1 year | +25.6% | +46.4% |
| Revenue growth (YoY) | +2.6% | +5.9% |
| Gross margin | 72.8% | 68.1% |
| Net margin | −1.6% | 0.8% |
| P/E (TTM) | 40.2× | 40.9× |
| Price / sales | 2.7× | 6.6× |
| Net cash | -$51.49B | -$27.42B |
| Dividend yield | 5.64% | 1.96% |
| Volatility (60d) | 19.8% | 23.4% |
| Short % of float | 2.4% | 0.7% |
| Next earnings | Nov 3, 2026 | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).